Purpose
to screen prioritized FDA-approved drugs against SARS-CoV-2 in vitro
Grantee
Division
Global Health
Date
MARCH 2020
Region served
GLOBAL
Committed amount
$717,958
Grant topic
Discovery and Translational Sciences,
Pneumonia & Pandemic Preparedness
Duration (months)
42
Grantee location
Baltimore, Maryland, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.